| Literature DB >> 17240111 |
Patricia Muñoz1, Maddalena Giannella, Maricela Valerio, Teresa Soria, Fernando Díaz, Javier Lopez Longo, Emilio Bouza.
Abstract
Infliximab, a tumor necrosis factor-alpha inhibitor, is increasingly used for the therapy of different inflammatory conditions. We report the first case of cryptococcal meningitis in a patient treated with infliximab and other immunosuppressive agents, and review a further 5 reported cryptococcal infections. All of them involved fungal pneumonia. Outcome was favorable in all cases.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17240111 DOI： 10.1016/j.diagmicrobio.2006.10.014
Source DB: PubMed Journal: Diagn Microbiol Infect Dis ISSN： 0732-8893 Impact factor: 2.803